| Dr Michael Alan Bailey, RPH, DPM | |
|
1739 Maybank Hwy, Charleston, SC 29412-2103 | |
| (843) 795-0792 | |
| (843) 762-3210 |
| Full Name | Dr Michael Alan Bailey |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1739 Maybank Hwy, Charleston, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245588052 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 010953 (South Carolina) | Primary |
| 183500000X | Pharmacist | 014625 (Georgia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Alan Bailey, RPH, DPM 1739 Maybank Hwy, Charleston, SC 29412-2103 Ph: (843) 795-0792 | Dr Michael Alan Bailey, RPH, DPM 1739 Maybank Hwy, Charleston, SC 29412-2103 Ph: (843) 795-0792 |
News Archive
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
Revealing the science behind the homespun advice, a team of researchers at Worcester Polytechnic Institute (WPI) has identified and measured the molecular forces that enable cranberry juice to fight off urinary tract infections in people.
Gaining 15 pounds or more over several years is the major contributor to progression of risk factors for heart disease and development of metabolic syndrome, while maintaining a stable weight - even in individuals considered obese – significantly reduces those risks, according to a study led by a Northwestern University researcher.
› Verified 7 days ago
Brianne Nicole Shokri, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Rutledge Ave, Charleston, SC 29425 Phone: 843-876-0253 | |
Michael Holt, R. PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1115 Old Towne Rd, Rite Aid Pharmacy, Charleston, SC 29407 Phone: 843-766-5593 Fax: 843-766-9787 | |
Dr. Micah Jordan Wallace, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2152 Savannah Hwy, Charleston, SC 29414 Phone: 843-556-8974 | |
Dr. Patrick S Cogan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011 | |
Dr. Samantha Kaye Pande, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1195 Remount Rd, Charleston, SC 29406 Phone: 843-744-8896 | |
Katlyn Johnson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 Sam Rittenberg Blvd, Charleston, SC 29407 Phone: 843-573-4776 | |
Dr. Erica Hanesworth, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 Bee St # 119, Charleston, SC 29401 Phone: 843-789-6473 Fax: 843-805-5798 |